These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22050253)

  • 1. A review of the methods, interpretation, and limitations of the urine drug screen.
    Markway EC; Baker SN
    Orthopedics; 2011 Nov; 34(11):877-81. PubMed ID: 22050253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Practical analysis of toxic substances useful for clinical toxicology--9--barbiturate].
    Komiyama Y; Hori Y; Namera A; Kuroki Y
    Chudoku Kenkyu; 2004 Jan; 17(1):79-84. PubMed ID: 15079929
    [No Abstract]   [Full Text] [Related]  

  • 4. Determination of Xipamide metabolite in human urine by high-performance liquid chromatography/diode-array detection, high-performance liquid chromatography/electrospray ionization mass spectrometry and gas chromatography/mass spectrometry.
    Kim Y; Han K; Paeng KJ
    Rapid Commun Mass Spectrom; 2004; 18(20):2505-12. PubMed ID: 15384135
    [No Abstract]   [Full Text] [Related]  

  • 5. Urine drug screening: a valuable office procedure.
    Standridge JB; Adams SM; Zotos AP
    Am Fam Physician; 2010 Mar; 81(5):635-40. PubMed ID: 20187600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs of abuse testing by tandem mass spectrometry: a rapid, simple method to replace immunoassays.
    Eichhorst JC; Etter ML; Rousseaux N; Lehotay DC
    Clin Biochem; 2009 Oct; 42(15):1531-42. PubMed ID: 19643101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid urine drug screens: diphenhydramine and methadone cross-reactivity.
    Rogers SC; Pruitt CW; Crouch DJ; Caravati EM
    Pediatr Emerg Care; 2010 Sep; 26(9):665-6. PubMed ID: 20838187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of ONTRAK TESTCUP, abuscreen ONTRAK, abuscreen ONLINE, and GC/MS urinalysis test results.
    Crouch DJ; Cheever ML; Andrenyak DM; Kuntz DJ; Loughmiller DL
    J Forensic Sci; 1998 Jan; 43(1):35-40. PubMed ID: 9456522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between drug screening by immunoassay and ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry in post-mortem urine.
    Sundström M; Pelander A; Ojanperä I
    Drug Test Anal; 2015 May; 7(5):420-7. PubMed ID: 24953563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary screening for methylphenidate (Ritalin) abuse: a comparison of liquid chromatography-tandem mass spectrometry, gas chromatography-mass spectrometry, and immunoassay methods.
    Eichhorst J; Etter M; Lepage J; Lehotay DC
    Clin Biochem; 2004 Mar; 37(3):175-83. PubMed ID: 14972638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced urine toxicology testing.
    Tenore PL
    J Addict Dis; 2010 Oct; 29(4):436-48. PubMed ID: 20924879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine drug screening in the medical setting.
    Hammett-Stabler CA; Pesce AJ; Cannon DJ
    Clin Chim Acta; 2002 Jan; 315(1-2):125-35. PubMed ID: 11728415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of clonazepam compliance by measurement of urinary concentration by immunoassay and LC-MS/MS in pain management population.
    West R; Pesce A; West C; Crews B; Mikel C; Almazan P; Rosenthal M; Latyshev S
    Pain Physician; 2010; 13(1):71-8. PubMed ID: 20119465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine toxicology screening by liquid chromatography time-of-flight mass spectrometry in a quaternary hospital setting.
    Pope JD; Black MJ; Drummer OH; Schneider HG
    Clin Biochem; 2021 Sep; 95():66-72. PubMed ID: 33989561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-testing methods and clinical interpretations of test results.
    Kapur BM
    Bull Narc; 1993; 45(2):115-54. PubMed ID: 7920539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid screening of drugs of abuse and their metabolites by gas chromatography/mass spectrometry: application to urinalysis.
    Strano-Rossi S; Molaioni F; Rossi F; Botrè F
    Rapid Commun Mass Spectrom; 2005; 19(11):1529-35. PubMed ID: 15880665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Urine Drug Screen by Gas Chromatography/Mass Spectrometry (GC/MS).
    Ramoo B; Funke M; Frazee C; Garg U
    Methods Mol Biol; 2016; 1383():125-31. PubMed ID: 26660182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hair analysis for illicit drugs by using capillary zone electrophoresis-electrospray ionization-ion trap mass spectrometry.
    Gottardo R; Bortolotti F; De Paoli G; Pascali JP; Miksík I; Tagliaro F
    J Chromatogr A; 2007 Aug; 1159(1-2):185-9. PubMed ID: 17240388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A downscaled multi-residue strategy for detection of anabolic steroids in bovine urine using gas chromatography tandem mass spectrometry (GC-MS3).
    Impens S; Van Loco J; Degroodt JM; De Brabander H
    Anal Chim Acta; 2007 Mar; 586(1-2):43-8. PubMed ID: 17386695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid diagnosis of drug intoxication using novel NAGINATA gas chromatography/mass spectrometry software.
    Ishida T; Kudo K; Naka S; Toubou K; Noguchi T; Ikeda N
    Rapid Commun Mass Spectrom; 2007; 21(18):3129-38. PubMed ID: 17708528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.